StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)

Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%

Gilead Sciences Equity method & fair value option biotech investments by Quarter

Equity method & fair value option biotech investments carrying value ($M) ($M)

QuarterlyAnnual

Gilead Sciences Equity method & fair value option biotech investments: $295M in Q2 2026, down 20.1% from a year earlier. That is the lowest of the 12 quarters on record here.

Latest, Q2 2026
295
Period ended Jun 30, 2026
Change on a year earlier
-20.1%
369 in Q2 2025
History
12 quarters
Since Q4 2022
Sources
11
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-06) ↗

Reported in Form 10-Q / 10-K Note 3 Fair Value & Note 4 Equity Securities.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEquity method & fair value option biotech investments carrying value ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026295-20.1%Form 10-Q (filed 2026-08-06) ↗
Q1 2026Mar 31, 2026308-14.2%Form 10-Q (filed 2026-05-07) ↗
Q4 2025Dec 31, 2025393+1.8%Form 10-Q (filed 2026-08-06) ↗
Q3 2025Sep 30, 2025393+2.9%Form 10-Q (filed 2025-11-07) ↗
Q2 2025Jun 30, 2025369-1.9%Form 10-Q (filed 2025-08-07) ↗
Q1 2025Mar 31, 20253590.0%Form 10-Q (filed 2025-05-07) ↗
Q4 2024Dec 31, 2024386+13.5%Form 10-K (filed 2026-02-24) ↗
Q3 2024Sep 30, 2024382–Form 10-Q (filed 2024-11-12) ↗
Q2 2024Jun 30, 2024376–Form 10-Q (filed 2024-08-08) ↗
Q1 2024Mar 31, 2024359–Form 10-Q (filed 2024-05-08) ↗
Q4 2023Dec 31, 2023340-19.6%Form 10-K (filed 2025-02-28) ↗
Q4 2022Dec 31, 2022423–Form 10-K (filed 2024-02-23) ↗

Breakdown

What makes up equity method & fair value option biotech investments

Cite this data

StockData. (2026). Gilead Sciences Equity method & fair value option biotech investments ($M), quarterly Q4 2022–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/eq-method-carrying

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.